Literature DB >> 8119104

Dextromethorphan attenuates the effects of ischemia on rabbit electroretinographic oscillatory potentials.

W Cao1, M Zaharia, A Drumheller, G Lafond, J R Brunette, F B Jolicoeur.   

Abstract

Dextromethorphan has been shown to protect against ischemic tissue damage. We investigated the effects of dextromethorphan on electroretinographic oscillatory potentials in retinal ischemia. Retinal ischemia was induced in rabbits by increasing intraocular pressure to 120 mm Hg for 30, 60 or 90 minutes. Dextromethorphan was intravenously administered before ischemia and maintained throughout the whole period of experiments. Oscillatory potentials were recorded before and during ischemia as well as 4 hours of recirculation after ischemia. As expected, all oscillatory potentials were decreased after 60 and 90 minutes of ischemia. However, after 30 minutes of ischemia followed by 4 hours of recirculation, amplitudes of P2 were elevated whereas those of P3 and P4 were decreased with normal P1 amplitudes. Dextromethorphan administration diminished the effects of 30 minutes of ischemia on oscillatory potentials and partially attenuated the effects of 60 minutes of ischemia, whereas the effects of 90 minutes of ischemia could not be reversed by dextromethorphan treatment. These results indicate that electroretinographic oscillatory potentials could be useful indicators to evaluate retinal function in the ischemic condition and that dextromethorphan can attenuate the effects of relatively short periods of ischemia on rabbit electroretinographic oscillatory potentials.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8119104     DOI: 10.1007/bf01203657

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  18 in total

1.  Recovery of retinal pigment epithelial function after ischemia in the rabbit.

Authors:  M Heike; M F Marmor
Journal:  Invest Ophthalmol Vis Sci       Date:  1991-01       Impact factor: 4.799

2.  An explanation of the "supernormal" b-wave in vitro.

Authors:  S J Cringle; V A Alder
Journal:  Invest Ophthalmol Vis Sci       Date:  1988-07       Impact factor: 4.799

3.  The effects of total acute ischaemia on the structure of the rabbit retina.

Authors:  N F Johnson; W S Foulds
Journal:  Exp Eye Res       Date:  1978-07       Impact factor: 3.467

4.  Dextromethorphan reduces neocortical ischemic neuronal damage in vivo.

Authors:  C P George; M P Goldberg; D W Choi; G K Steinberg
Journal:  Brain Res       Date:  1988-02-09       Impact factor: 3.252

5.  Ketamine suppresses ischemic injury in the rabbit retina.

Authors:  Y Tsukahara; N P Blair; D C Eappen; J J Moy; A Takahashi; G K Shah; M A Viana
Journal:  Invest Ophthalmol Vis Sci       Date:  1992-04       Impact factor: 4.799

6.  Rod-cone differences in response to retinal ischemia in rabbit.

Authors:  J R Brunette; P Olivier; M Zaharia; P Blondeau; G Lafond
Journal:  Doc Ophthalmol       Date:  1986-11-15       Impact factor: 2.379

7.  Electrophysiological properties of neurones following mild and acute retinal ischaemia.

Authors:  H Ikeda; M W Hankins; T Asai; E A Dawes
Journal:  Exp Eye Res       Date:  1992-09       Impact factor: 3.467

8.  Involvement of excitatory neurotransmitters in the damage produced in chick embryo retinas by anoxia and extracellular high potassium.

Authors:  P David; M Lusky; V I Teichberg
Journal:  Exp Eye Res       Date:  1988-05       Impact factor: 3.467

9.  Dextromethorphan alters cerebral blood flow and protects against cerebral injury following focal ischemia.

Authors:  G K Steinberg; E H Lo; D M Kunis; G A Grant; A Poljak; R DeLaPaz
Journal:  Neurosci Lett       Date:  1991-12-09       Impact factor: 3.046

10.  NMDA antagonist neurotoxicity: mechanism and prevention.

Authors:  J W Olney; J Labruyere; G Wang; D F Wozniak; M T Price; M A Sesma
Journal:  Science       Date:  1991-12-06       Impact factor: 47.728

View more
  1 in total

1.  Hypobaric hypoxia reduces the amplitude of oscillatory potentials in the human ERG.

Authors:  Márta Janáky; Andor Grósz; Erika Tóth; Krisztina Benedek; György Benedek
Journal:  Doc Ophthalmol       Date:  2007-01-09       Impact factor: 2.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.